Compounds > haloperidol

haloperidol and gyki 52466

haloperidol has been researched along with gyki 52466 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, WJ; Zadow, B1
Hauber, W; Waldenmeier, MT1
Andersen, R; Hauber, W1
Kratzer, U; Kretschmer, BD; Schmidt, WJ1
Kulak, A; Riedinger, K; Schmidt, WJ; von Ameln-Mayerhofer, A1

Other Studies

5 other study(ies) available for haloperidol and gyki 52466

ArticleYear
The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy.
    Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 349, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Drug Interactions; Ergolines; Haloperidol; Levodopa; Male; Pilot Projects; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA

1994
The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.
    European journal of pharmacology, 1994, May-02, Volume: 256, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Catalepsy; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate

1994
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine.
    Naunyn-Schmiedeberg's archives of pharmacology, 1993, Volume: 348, Issue:5

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Haloperidol; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

1993
Riluzole, a glutamate release inhibitor, and motor behavior.
    Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 358, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Benzazepines; Benzodiazepines; Catalepsy; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Locomotion; Male; Motor Activity; N-Methylaspartate; Neuropsychological Tests; Postural Balance; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Riluzole; Smell

1998
The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization.
    Behavioural brain research, 2011, Mar-17, Volume: 218, Issue:1

    Topics: Analysis of Variance; Animals; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate

2011